Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 NKTR-105 Demonstrates Superior Antitumor Activity and Improved Pharmacokinetics Over Docetaxel in Preclinical Studies Presented at AACR Apr 22, 2009 Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the 29th Annual Cowen and Company Healthcare Conference in Boston Mar 10, 2009 Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC) Mar 02, 2009 Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results Feb 24, 2009 Dosing Begins in Phase 1 Clinical Study Evaluating NKTR-105 in Cancer Patients With Refractory Solid Tumors Feb 17, 2009 Nektar to Announce Year-End 2008 Financial Results on Wednesday, February 25, 2009 After Close of U.S.-Based Financial Markets Feb 11, 2009 Nektar Announces Retirement of Irwin Lerner from Board of Directors Jan 29, 2009 First Patient Dosed in Phase 2 Clinical Trial of NKTR-102 in Ovarian Cancer Jan 13, 2009 Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco Jan 05, 2009 Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million Dec 31, 2008 Pagination First page « first Previous page ‹ previous … Page 39 Page 40 Page 41 Page 42 Current page 43 Page 44 Page 45 Page 46 Page 47 … Next page next › Last page last »